Case reports that high-dose-rate brachytherapy using custom-designed mouthpiece mold for early-stage squamous cell carcinoma of the hard palate is useful
This study might show that HDR-customized MBT is useful for early-stage SCCHP and might be an alternative curative treatment option for them to preserve oral function.
Authors
- Satoshi Ikeda (ORCID: https://orcid.org/0000-0001-8163-8038)
- Koji Masui (ORCID: https://orcid.org/0000-0001-9208-1909)
- Norihiro Aibe (ORCID: https://orcid.org/0000-0002-6595-0205)
- Kanako Kawabata
- Fumishige Oseko (ORCID: https://orcid.org/0000-0001-6870-8361)
- Tomohiro Kajikawa
- Kei Yamada (ORCID: https://orcid.org/0000-0003-3717-1607)
- Yuki Yoshino (ORCID: https://orcid.org/0000-0003-0029-3467)
- Tadashi Takenaka
- Takuya Kimoto
- S. Nagasawa
- Hideya Yamazaki
- Gen Suzuki
- Tadahiro Kawamoto
Institutions
- Osaka Medical and Pharmaceutical University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Osaka University of Pharmaceutical Sciences (JP)
Publication Details
- Journal
- Radiation Oncology
- Published
- 2026-01-12
- DOI
- https://doi.org/10.1186/s13014-025-02775-9
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00